ArticlePLoS biology2025

MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing.

Izzat T Raheem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.